Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia

Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia


Play all audios:


Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this


journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now


Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer


support AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Service d'Hematologie, Hôpital Edouard Herriot, 69437, Lyon, Cedex 03, Lyon, France X Thomas, D Fiere & ✠E Archimbaud Authors *


X Thomas View author publications You can also search for this author inPubMed Google Scholar * D Fiere View author publications You can also search for this author inPubMed Google Scholar


* ✠E Archimbaud View author publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE


Thomas, X., Fiere, D. & Archimbaud, ✠. Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia. _Leukemia_ 12, 1503–1505 (1998).


https://doi.org/10.1038/sj.leu.2401126 Download citation * Received: 20 April 1998 * Accepted: 15 May 1998 * Published: 02 September 1998 * Issue Date: 01 September 1998 * DOI:


https://doi.org/10.1038/sj.leu.2401126 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not


currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative